Annual Current Assets
$37.84 M
-$79.70 M-67.81%
December 31, 2023
Summary
- As of February 12, 2025, EIGR annual total current assets is $37.84 million, with the most recent change of -$79.70 million (-67.81%) on December 31, 2023.
- During the last 3 years, EIGR annual current assets has fallen by -$99.97 million (-72.54%).
- EIGR annual current assets is now -72.54% below its all-time high of $137.81 million, reached on December 31, 2020.
Performance
EIGR Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$37.84 M
-$16.79 M-30.73%
December 31, 2023
Summary
- As of February 12, 2025, EIGR quarterly total current assets is $37.84 million, with the most recent change of -$16.79 million (-30.73%) on December 31, 2023.
- Over the past year, EIGR quarterly current assets has dropped by -$79.70 million (-67.81%).
- EIGR quarterly current assets is now -77.73% below its all-time high of $169.89 million, reached on March 31, 2021.
Performance
EIGR Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
EIGR Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -67.8% | -67.8% |
| 3 y3 years | -72.5% | -72.5% |
| 5 y5 years | -62.9% | -62.9% |
EIGR Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -67.8% | at low | -76.0% | at low |
| 5 y | 5-year | -72.5% | at low | -77.7% | at low |
| alltime | all time | -72.5% | +7498.2% | -77.7% | +104.0% |
Eiger BioPharmaceuticals Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $987.00 K(-62.1%) | $37.84 M(-30.7%) |
| Sep 2023 | - | $54.62 M(-22.5%) |
| Jun 2023 | - | $70.48 M(-27.3%) |
| Mar 2023 | - | $96.91 M(-17.5%) |
| Dec 2022 | $2.60 M(-88.7%) | $117.53 M(-17.4%) |
| Sep 2022 | - | $142.29 M(-9.8%) |
| Jun 2022 | - | $157.70 M(+7.0%) |
| Mar 2022 | - | $147.36 M(+42.6%) |
| Dec 2021 | $23.04 M(+298.0%) | $103.36 M(+4.3%) |
| Sep 2021 | - | $99.09 M(-16.6%) |
| Jun 2021 | - | $118.80 M(-30.1%) |
| Mar 2021 | - | $169.89 M(+23.3%) |
| Dec 2020 | $5.79 M(+21.7%) | $137.81 M(+2.1%) |
| Sep 2020 | - | $134.94 M(+38.6%) |
| Jun 2020 | - | $97.34 M(+18.0%) |
| Mar 2020 | - | $82.47 M(-17.9%) |
| Dec 2019 | $4.75 M(+688.6%) | $100.38 M(-12.3%) |
| Sep 2019 | - | $114.41 M(-10.9%) |
| Jun 2019 | - | $128.37 M(+45.2%) |
| Mar 2019 | - | $88.39 M(-13.2%) |
| Dec 2018 | $603.00 K | $101.84 M(+52.5%) |
| Sep 2018 | - | $66.80 M(-10.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $74.98 M(+121.4%) |
| Mar 2018 | - | $33.86 M(-20.3%) |
| Dec 2017 | $391.00 K(+78.5%) | $42.49 M(+28.3%) |
| Sep 2017 | - | $33.13 M(-19.8%) |
| Jun 2017 | - | $41.28 M(-16.7%) |
| Mar 2017 | - | $49.55 M(-18.1%) |
| Dec 2016 | $219.00 K(+2090.0%) | $60.52 M(+5.8%) |
| Sep 2016 | - | $57.21 M(+22.9%) |
| Jun 2016 | - | $46.56 M(-24.5%) |
| Mar 2016 | - | $61.67 M(+82.1%) |
| Dec 2015 | $10.00 K(-99.0%) | $33.88 M(-11.1%) |
| Sep 2015 | - | $38.09 M(-35.7%) |
| Jun 2015 | - | $59.21 M(-18.1%) |
| Mar 2015 | - | $72.26 M(-18.0%) |
| Dec 2014 | $1.03 M(-60.6%) | $88.08 M(-8.3%) |
| Sep 2014 | - | $96.01 M(+85.5%) |
| Jun 2014 | - | $51.76 M(-11.1%) |
| Mar 2014 | - | $58.21 M(+213.8%) |
| Dec 2013 | $2.60 M(-13.0%) | $18.55 M(-20.7%) |
| Sep 2013 | - | $23.40 M(-17.3%) |
| Jun 2013 | - | $28.28 M |
| Dec 2012 | $2.99 M(+2068.1%) | - |
| Dec 2011 | $138.00 K | - |
FAQ
- What is Eiger BioPharmaceuticals annual total current assets?
- What is the all time high annual current assets for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals annual current assets year-on-year change?
- What is Eiger BioPharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals quarterly current assets year-on-year change?
What is Eiger BioPharmaceuticals annual total current assets?
The current annual current assets of EIGR is $37.84 M
What is the all time high annual current assets for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high annual total current assets is $137.81 M
What is Eiger BioPharmaceuticals annual current assets year-on-year change?
Over the past year, EIGR annual total current assets has changed by -$79.70 M (-67.81%)
What is Eiger BioPharmaceuticals quarterly total current assets?
The current quarterly current assets of EIGR is $37.84 M
What is the all time high quarterly current assets for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high quarterly total current assets is $169.89 M
What is Eiger BioPharmaceuticals quarterly current assets year-on-year change?
Over the past year, EIGR quarterly total current assets has changed by -$79.70 M (-67.81%)